Related Experiment Video
Updated: Aug 9, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Precision medicine in the treatment of pediatric cancers]
Khalil Ben Hassine1, Francesco Ceppi2, Frederic Baleydier1,3
1Plateforme de recherche CANSEARCH en oncologie et hématologie pédiatrique, Faculté de médecine, Département de la femme, de l'enfant et de l'adolescent, Université de Genève, Centre médical universitaire, 1206 Genève.
Abstract:
Despite the progress in cure rates for pediatric cancers, several challenges remain, such as the management of diseases with poor prognosis. The efficacy of intensified chemotherapies is also accompanied by increased risks of severe acute and chronic toxicities. Thus, therapies specifically targeting tumor cells, or inhibiting oncogenic molecular aberrations, could provide more effective and less toxic treatments for pediatric cancers. Personalization of chemotherapies through pharmacogenetics and precision dosing could also improve the efficacy and toxicity of chemotherapies. In this review, we describe precision medicine strategies implemented or undergoing clinical evaluation in the treatment of pediatric cancers.
Insights
Precision medicine offers improved, less toxic treatments for pediatric cancers by targeting specific tumor cells and personalizing chemotherapy. This approach aims to overcome challenges in treating aggressive childhood cancers and reduce treatment side effects.
Area of Science:
- Pediatric Oncology
- Cancer Therapeutics
- Molecular Oncology
Background:
- Pediatric cancer cure rates have improved, but challenges persist, particularly in managing poor-prognosis diseases.
- Intensified chemotherapies increase cure rates but also elevate risks of severe acute and chronic toxicities.
- Current treatments for pediatric cancers face limitations in efficacy and toxicity profiles.
Approach:
- Reviewing precision medicine strategies for pediatric cancers.
- Evaluating therapies targeting tumor cells and inhibiting oncogenic molecular aberrations.
- Exploring pharmacogenetics and precision dosing for personalized chemotherapy.
Key Points:
- Targeted therapies and molecularly-driven treatments offer enhanced efficacy and reduced toxicity.
- Pharmacogenetics and precision dosing can optimize chemotherapy effectiveness and safety.
- Precision medicine strategies are crucial for advancing pediatric cancer care.
Conclusions:
- Precision medicine represents a paradigm shift in treating pediatric cancers.
- Personalized approaches hold significant promise for improving outcomes and minimizing side effects in children with cancer.
- Continued clinical evaluation of precision medicine strategies is essential for pediatric oncology.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Tumor Immunotherapy

